{"schema_version":"secwatch.filing_event.v1","accession":"0001428336-24-000005","form_type":"8-K","ticker":"HQY","cik":"0001428336","company_name":"HEALTHEQUITY, INC.","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.162740+00:00","generated_at":"2026-06-05T21:55:06.609965+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"HealthEquity reports 9% HSA growth to 8.7M accounts, raises FY24 guidance, affirms FY25 outlook","bullets":["HSAs 8.69M (+9% YoY); HSA Assets $25.2B (+14%); Total Accounts 15.7M (+5%).","Q4 new HSAs from sales 497K (+12% YoY); record organic growth.","FY24 guidance raised: Revenue $995M-$1B, Non-GAAP EPS $2.20-$2.24.","FY25 guidance reaffirmed: Revenue $1.14B-$1.16B, Adj. EBITDA margin 38%-39%.","CFO targets doubling non-GAAP EPS over three years as HSA cash yields rise."],"urls":{"canonical":"https://secwatch.observer/filing/0001428336-24-000005","json":"https://secwatch.observer/filing/0001428336-24-000005.json","markdown":"https://secwatch.observer/filing/0001428336-24-000005.md","text":"https://secwatch.observer/filing/0001428336-24-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1428336/000142833624000005/0001428336-24-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1428336/000142833624000005/hqy-20240221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T21:55:06.609965+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"053e63d3a3694e10310b879dba83bca38cebb643","claim":"HEALTHEQUITY, INC. reported the fiscal year ending January 31, 2025 results: revenue $1.140 billion to $1.160 billion. Guidance reaffirmed.","evidence_excerpt":"For the fiscal year ending January 31, 2025, the Company affirmed its previously provided outlook, which assumes an average annualized yield on HSA cash of approximately 3%, as follows: • Revenue in the range of $1.140 billion to $1.160 billion;","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1428336/000142833624000005/0001428336-24-000005-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ending January 31, 2025"},{"label":"Revenue","value":"$1.140 billion to $1.160 billion"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"2a4c6e31aeacb8ff7d4932333a55792165ec6e4c","claim":"HEALTHEQUITY, INC. reported the fiscal year ended January 31, 2024 results: revenue $995 million to $1 billion, net income $49 million to $52 million, EPS $0.56 to $0.60. Guidance raised.","evidence_excerpt":"For the fiscal year ended January 31, 2024, the Company revised its previously provided outlook as follows: • Revenue in the range of $995 million to $1 billion; • Net income in the range of $49 million to $52 million; • Net income per diluted share in the range of $0.56 to $0.60;","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1428336/000142833624000005/0001428336-24-000005-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended January 31, 2024"},{"label":"Revenue","value":"$995 million to $1 billion"},{"label":"Net income","value":"$49 million to $52 million"},{"label":"EPS","value":"$0.56 to $0.60"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}